Advertisement

Topics

Pixium Vision (PIX) - H118 update reflects continued Prima progress

06:52 EDT 9 Aug 2018 | Edison Investment Research

Edison Investment Research - Pharmaceutical & healthcare - Pixium Vision: Pixium’s Prima sub-retinal wireless implant continues to advance through human feasibility trials. The EU study recently reached full enrolment and a US study is slated to start implantations in Q318. Using a risk-adjusted NPV model, we obtain a pipeline rNPV of €90.6m, vs €77.4m previously.
ISIN: FR0011950641

Original Article: Pixium Vision (PIX) - H118 update reflects continued Prima progress

NEXT ARTICLE

More From BioPortfolio on "Pixium Vision (PIX) - H118 update reflects continued Prima progress"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...